EFM

E Fund Management Portfolio holdings

AUM $2.1B
1-Year Return 23.31%
This Quarter Return
-25%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
10 Year Return
AUM
$2.39B
AUM Growth
Cap. Flow
+$2.39B
Cap. Flow %
100%
Top 10 Hldgs %
77.94%
Holding
271
New
271
Increased
Reduced
Closed

Top Buys

1
BABA icon
Alibaba
BABA
$947M
2
JD icon
JD.com
JD
$216M
3
PDD icon
Pinduoduo
PDD
$195M
4
BIDU icon
Baidu
BIDU
$171M
5
NTES icon
NetEase
NTES
$111M

Top Sells

No sells this quarter

Sector Composition

1 Consumer Discretionary 62.14%
2 Communication Services 18.47%
3 Technology 9.22%
4 Healthcare 3.01%
5 Financials 1.76%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HGEN
251
DELISTED
HUMANIGEN, INC.
HGEN
$149K 0.01%
+25,054
New +$149K
AGEN
252
Agenus
AGEN
$132M
$139K 0.01%
+1,351
New +$139K
CVM icon
253
CEL-SCI Corp
CVM
$77.6M
$129K 0.01%
+393
New +$129K
IBRX icon
254
ImmunityBio
IBRX
$2.2B
$123K 0.01%
+12,638
New +$123K
KDMN
255
DELISTED
Kadmon Holdings, Inc.
KDMN
$122K 0.01%
+14,053
New +$122K
MNKD icon
256
MannKind Corp
MNKD
$1.62B
$121K 0.01%
+27,776
New +$121K
KPTI icon
257
Karyopharm Therapeutics
KPTI
$59.6M
$119K 0.01%
+1,368
New +$119K
AKBA icon
258
Akebia Therapeutics
AKBA
$809M
$107K ﹤0.01%
+37,123
New +$107K
SGMO icon
259
Sangamo Therapeutics
SGMO
$161M
$100K ﹤0.01%
+11,046
New +$100K
IMGN
260
DELISTED
Immunogen Inc
IMGN
$95K ﹤0.01%
+16,798
New +$95K
IMVT icon
261
Immunovant
IMVT
$2.88B
$91K ﹤0.01%
+10,474
New +$91K
SPPI
262
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$83K ﹤0.01%
+38,190
New +$83K
VBIV
263
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$80K ﹤0.01%
+862
New +$80K
VSTM icon
264
Verastem
VSTM
$628M
$74K ﹤0.01%
+1,995
New +$74K
EPZM
265
DELISTED
Epizyme, Inc
EPZM
$68K ﹤0.01%
+13,338
New +$68K
RIGL icon
266
Rigel Pharmaceuticals
RIGL
$693M
$60K ﹤0.01%
+1,655
New +$60K
CPRX icon
267
Catalyst Pharmaceutical
CPRX
$2.4B
$57K ﹤0.01%
+10,838
New +$57K
TCRT icon
268
Alaunos Therapeutics
TCRT
$4.23M
$41K ﹤0.01%
+151
New +$41K
VTGN icon
269
VistaGen Therapeutics
VTGN
$113M
$38K ﹤0.01%
+459
New +$38K
GERN icon
270
Geron
GERN
$880M
$30K ﹤0.01%
+21,560
New +$30K
LCTX icon
271
Lineage Cell Therapeutics
LCTX
$276M
$28K ﹤0.01%
+11,095
New +$28K